There are no adverse events reported in 0.2 mg/kg/day and 0.4 mg/kg/day groups; while in Escin 0.6 mg/kg/day group, one patient (3%) occurred grade 3 Anemia, another patient (3%) occurred grade 3 ALT elevations. The gene discussed is GPT; the disease is anemia (phenotype).